Valve Repair Achieved with Easy-to-Install Ring or Band

A new contestant in the $115-million global heart valve repair market, the ATS Simulus annuloplasty line of products by ATS Medical was cleared for release by the FDA at the end of January. Designed with input from cardiac surgeons, the devices emphasize ease of implantation.
Available in a flexible ring (the ATS Simulus FLX-O Ring) or a flexible band (the ATS Simulus FLX-C Band), the products accommodate various approaches to valve repair. They can be used in both the mitral and tricuspid position.
Annuloplasty rings and bands are used in those cases where repair of  the patient's heart valve is preferable to the complete replacement of the valve. It has been well documented that the shape of heart valves change during the cardiac cycle. The ATS Simulus annuloplasty products are designed to maintain the normal physiologic function of the heart valve. They have been designed with the input of cardiac surgeons with a focus on the ease of implantation.
Genesee BioMedical Inc., a Denver-based innovator of cardiac surgery instruments and devices is the exclusive partner of ATS Medical for the development and manufacture of a full line of annuloplasty products.